{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Meo SA"],"funding":["King Saud University, Riyadh, Saudi Arabia"],"pagination":["18767"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11322667"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(1)"],"pubmed_abstract":["The vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an important public health strategy to prevent people from the pandemic. Vaccines are a game-changing tool, it is essential to understand the adverse events after COVID-19 vaccination. This study explored the adverse events of COVID-19 Vaccination Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Johnson and Johnson on Guillain-Barré Syndrome (GBS). In this study, initially 128 documents were identified from the databases, including Pub-Med, Web of Science-Clarivate Analytics, Scopus, and Google Scholar. The articles on COVID-19 vaccination and GBs were searched using the keywords \"SARS-CoV-2, COVID-19, Vaccination, and Guillain Barré Syndrome, GBS\", finally, 16 documents were included in the analysis and s"],"journal":["Scientific reports"],"pubmed_title":["Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barre Syndrome."],"pmcid":["PMC11322667"],"funding_grant_id":["(RSP-2024 R47)."],"pubmed_authors":["Meo SA","Abukhalaf FA","Shaikh N","Meo AS"],"additional_accession":[]},"is_claimable":false,"name":"Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain-Barre Syndrome.","description":"The vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is an important public health strategy to prevent people from the pandemic. Vaccines are a game-changing tool, it is essential to understand the adverse events after COVID-19 vaccination. This study explored the adverse events of COVID-19 Vaccination Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Johnson and Johnson on Guillain-Barré Syndrome (GBS). In this study, initially 128 documents were identified from the databases, including Pub-Med, Web of Science-Clarivate Analytics, Scopus, and Google Scholar. The articles on COVID-19 vaccination and GBs were searched using the keywords \"SARS-CoV-2, COVID-19, Vaccination, and Guillain Barré Syndrome, GBS\", finally, 16 documents were included in the analysis and s","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Aug","modification":"2026-05-02T12:25:26.546Z","creation":"2025-04-21T22:09:00.215Z"},"accession":"S-EPMC11322667","cross_references":{"pubmed":["39138276"],"doi":["10.1038/s41598-024-66999-7"]}}